Sharda Cropchem
Stock Snapshot
Price Performance
Vista Outlook
View Technicals Analysis →Basis of our Recommendation
Sharda Cropchem's management has expressed a confident outlook for FY27, projecting revenue growth of 10-15% and stable gross margins around 35%. This optimism is underpinned by a robust registration pipeline of 1,004 pending applications, which is expected to drive future product launches and market entries, particularly in North America and Latin America. The company's asset-light, IP-driven model allows for scalable growth with limited capital requirements, positioning it well to capitalize on structural tailwinds in the global crop protection industry. Despite facing geopolitical risks and forex volatility, Sharda's debt-free balance sheet and strong cash position provide a solid foundation for long-term expansion. Vista's financial outlook reflects these developments, anticipating moderate revenue growth and stable margins, supported by improving pricing power in the agribusiness sector. The expected upside remains attractive, with a 12-month target price of approximately 1,097.45. Over the next 12-24 months, key opportunities include leveraging the extensive registration portfolio and expanding market presence, while watchpoints include potential delays in product registrations and external supply chain dependencies
Why We Like This Stock
- Management projects revenue growth of 10-15% for FY27, driven by a robust registration pipeline and improving pricing
- The company's asset-light, IP-driven model allows for scalable growth with limited capital requirements, enhancing its competitive position
- A debt-free balance sheet provides financial stability, enabling strategic investments and long-term expansion
Things To Watch Out For
- Geopolitical instability and forex volatility pose risks to operational performance and profitability
- Delays in converting the substantial product registration pipeline could hinder growth expectations
- Cautious investor sentiment may impact stock performance despite attractive valuation metrics
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 3,163 | 4,320 | 5,268 | 5,158 | 5,714 |
| Profit Before Tax (Cr.) | 72 | 371 | 856 | 939 | 1,033 |
| PBT Margin | 2.3% | 8.6% | 1624.9% | 18.2% | 18.1% |
| Net Profit (Cr.) | 43 | 319 | 708 | 781 | 859 |
| Earnings Per Share | 4.8 | 35.4 | 78.5 | 86.5 | 95.3 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| Anand Rathi | ▲ Buy | 1,350 | 31-Jul-2026 |
| Khambatta Securities | ▲ Buy | 1,325 | 18-May-2026 |
Company Overview
Show Company Profile
Sharda Cropchem Limited, a crop protection chemical company, provides various formulations and generic active ingredients worldwide. It offers agrochemical products, including insecticides, fungicides, herbicides, veterinary drugs, plant growth regulators, fumigants, regulators, rodenticides, metalaxyl, propiconazole, phenthoate, pendimethalin, and dithianon; and biocides. The company also provides conveyor belts, such as textile ply, rough top, steel cord, chevron/pattern, elevator, sidewall, pipe, and PVC/PVG solid woven conveyor belts, as well as cotton transmission belts, PVC and polyurethane light duty belting products, and V-belts. In addition, it offers industrial chemicals used in water treatment, food and food ingredients, and other industrial applications; and dyes and dye intermediates, as well as general chemicals. Further, the company supplies and distributes pharmaceuticals and intermediates products, including prothioconazole, azoxystrobin, P-nitrophenol - parathion-methyl, 2,4-dichloroacetophenone - propiconazole, cyclopropanecarboxylic acid - trinexapac-ethyl, and P-fluorobenzaledehyde - cyfluthrin. Sharda Cropchem Limited was founded in 1987 and is based in Mumbai, India.